試す - 無料

Labour codes: Standardising compliance for life sciences sector

Bio Spectrum

|

February 2026

The Government has consolidated 29 labour laws into four comprehensive Labour Codes. This move for across sectors is being seen as labour-friendly; however, a certain section of society seems to be wary. Experts from the life sciences sector welcome the new move on one hand, but express concern about the likely challenges.

- Sanjiv Das

Labour codes: Standardising compliance for life sciences sector

The Government of India has announced the implementation of the four Labour Codes in November 2025. The laws, the Code on Wages, 2019; the Industrial Relations Code, 2020; the Code on Social Security, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020 (OSH) came into effect from November 21, 2025, rationalising 29 existing labour laws. The implementation of the four Labour Codes comes at a time when there has been a hue and cry over malpractices being followed by companies. News of mass layoffs is nothing new, and for an employee, it has far-reaching impacts when it comes to mental stress and agony.

imageThe need for the labour law

Many of India’s labour laws were framed in the pre-Independence and early post-Independence era (1930s—1950s). This was at a time when the economy and world of work were fundamentally different. While most major economies have updated and consolidated their labour regulations in recent decades, India continued to operate under fragmented, complex and in several parts outdated provisions spread across 29 Central labour laws. These restrictive frameworks struggled to keep pace with changing economic realities and evolving forms of employment, creating uncertainty and increasing compliance burden for both workers and industry.

How will it impact the life sciences sector?

Bio Spectrum からのその他のストーリー

Bio Spectrum

Park Medi World buys KP Institute of Medical Sciences for Rs 245 Cr

Park Medi World Limited, North India's second largest chain of hospitals, has agreed to acquire KP Institute of Medical Sciences (KPIMS), in an all-cash transaction amounting to Rs 245 crore.

time to read

1 min

February 2026

Bio Spectrum

Decode Age raises Rs 14.48 Cr to advance longevity science and gut microbiome research

Bengaluru-based Decode Age, a longevity science organisation focused on ageing biology, biomarker research and gut microbiome science, has raised Rs 14.48 crore in its Pre Series A funding round led by Dr Krishna Prasad Chigurupati, Chairman and Managing Director, Granules India Limited.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Havih Envirosciences announces partnership with Andhra Pradesh

Havih Envirosciences, a subsidiary of Maxwell Biosciences, has announced a strategic partnership with the Government of Andhra Pradesh to establish advanced pharmaceutical research and production capabilities in the state.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Biofabri and Bharat Biotech ink technology transfer agreement to advance global access to MTBVAC

Biofabri, a global human vaccine development company that is part of Spain-based Zendal group, and Bharat Biotech International Limited (BBIL) in Hyderabad, a global leader in vaccine innovation and manufacturing, have announced the signing of a Technology Transfer Agreement.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Care ADHD expands global operations with first GCC in India

Care ADHD, one of the United Kingdom's fastest growing digital mental health companies and a key partner to the NHS, has announced the opening of its first Global Capability Centre (GCC) in India - Bengaluru.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

PM launches Ayush Mark, setting global quality benchmarks for India's traditional medicine

In a historic and visionary move that marks a defining moment for India's traditional medicine ecosystem, Prime Minister (PM) Narendra Modi has launched the Ayush Mark, establishing a globally aligned quality certification framework for Ayush products and services.

time to read

1 min

February 2026

Bio Spectrum

US announces $50 B in awards to strengthen rural healthcare

The Centers for Medicare & Medicaid Services (CMS) has announced that all 50 states will receive awards under the Rural Health Transformation Program, a $50 billion initiative established under President Trump's Working Families Tax Cuts legislation (Public Law 119-21) to strengthen and modernise healthcare in rural communities across the country.

time to read

1 min

February 2026

Bio Spectrum

Novo Nordisk launches world's most prescribed GLP-1 drug Ozempic in India

Novo Nordisk, a global healthcare company, has announced the launch of Ozempic (injectable semaglutide) in India.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Vyome inches towards US FDA approval to enter $1B worth malignant fungating wound market

Vyome Holdings, Inc., a startup based both in the US & India, has announced the final results from an investigator-initiated Phase 2 proof of concept study of VT-1953 topical gel in people with malignant fungating wounds (MFW). VT-1953, a first-in-class immunomodulator for this indication, achieved both its primary & secondary endpoints.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Symbiotec Pharmalab files DRHP with SEBI for IPO aggregating upto Rs 2180 Cr

Indore-based Symbiotec Pharmalab, a research and development-driven, science-based pharmaceutical and biotechnology company with capabilities across three platforms-organic chemistry, biotechnology and complex injectables, has filed its Draft Red Herring Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI).

time to read

1 min

February 2026

Listen

Translate

Share

-
+

Change font size